199 related articles for article (PubMed ID: 15367394)
1. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.
Borst SE; Lee JH; Conover CF
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E222-7. PubMed ID: 15367394
[TBL] [Abstract][Full Text] [Related]
2. Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase.
Borst SE; Conover CF; Carter CS; Gregory CM; Marzetti E; Leeuwenburgh C; Vandenborne K; Wronski TJ
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E507-14. PubMed ID: 17488806
[TBL] [Abstract][Full Text] [Related]
3. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
Jia Y; Cue YG; Wang XD; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):38-41. PubMed ID: 15704680
[TBL] [Abstract][Full Text] [Related]
4. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
[TBL] [Abstract][Full Text] [Related]
5. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
Bandivdekar AH; Karp R; Sundaram K; Kumar N
J Androl; 2000; 21(2):268-75. PubMed ID: 10714822
[TBL] [Abstract][Full Text] [Related]
6. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
[TBL] [Abstract][Full Text] [Related]
7. Orchiectomized Fischer 344 male rat models body composition in hypogonadal state.
Borst SE; Conover CF
Life Sci; 2006 Jun; 79(4):411-5. PubMed ID: 16507309
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
[TBL] [Abstract][Full Text] [Related]
9. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
10. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
11. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
12. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
13. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
[TBL] [Abstract][Full Text] [Related]
14. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice.
Axell AM; MacLean HE; Plant DR; Harcourt LJ; Davis JA; Jimenez M; Handelsman DJ; Lynch GS; Zajac JD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E506-16. PubMed ID: 16621900
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone.
Kamischke A; Weinbauer GF; Semjonow A; Lerchl A; Richter KD; Nieschlag E
J Androl; 1999; 20(5):601-10. PubMed ID: 10520572
[TBL] [Abstract][Full Text] [Related]
16. Testosterone undecanoate: a useful tool for testosterone administration in rats.
Callies F; Kollenkirchen U; von zur Mühlen C; Tomaszewski M; Beer S; Allolio B
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):203-8. PubMed ID: 12845558
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
Seidlová-Wuttke D; Jarry H; Pitzel L; Wuttke W
Maturitas; 2005 Jun; 51(2):177-86. PubMed ID: 15917159
[TBL] [Abstract][Full Text] [Related]
18. Actions of 5alpha-reductase inhibitors on the epididymis.
Robaire B; Henderson NA
Mol Cell Endocrinol; 2006 May; 250(1-2):190-5. PubMed ID: 16476520
[TBL] [Abstract][Full Text] [Related]
19. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
20. Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate.
Corradi LS; Góes RM; Vilamaior PS; Taboga SR
Microsc Res Tech; 2009 Dec; 72(12):939-50. PubMed ID: 19484778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]